Cargando…
Hormonal Receptor Immunochemistry Heterogeneity and (18)F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers
INTRODUCTION: We aimed to investigate whether (18)F-FDG PET metabolic heterogeneity reflects the heterogeneity of estrogen receptor (ER) and progesterone receptor (PR) expressions within luminal non-metastatic breast tumors and if it could help in identifying patients with worst event-free survival...
Autores principales: | Aide, Nicolas, Elie, Nicolas, Blanc-Fournier, Cécile, Levy, Christelle, Salomon, Thibault, Lasnon, Charline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837029/ https://www.ncbi.nlm.nih.gov/pubmed/33511077 http://dx.doi.org/10.3389/fonc.2020.599050 |
Ejemplares similares
-
Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics
por: Aide, Nicolas, et al.
Publicado: (2018) -
Assessment of alteration in liver (18)F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
por: Salomon, Thibault, et al.
Publicado: (2017) -
Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic (18) F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients
por: Aide, Nicolas, et al.
Publicado: (2022) -
A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
por: Aide, Nicolas, et al.
Publicado: (2021) -
Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)